COVID-19 vaccines activate long-lasting immune system T-cells that target coronavirus variants of concern, including Delta and Omicron, new research shows. The research team at the La Jolla Institute for Immunology in California studied adults who were fully vaccinated with the Pfizer, Moderna, Johnson & Johnson or Novavax vaccines, but had not received boosters. “The vast…  read on >  read on >

Two rheumatoid arthritis drugs show potential for lowering the risk of Parkinson’s disease, new research shows. Some previous studies have found that people with rheumatoid arthritis have a lower risk of Parkinson’s, and it was suggested that a class of rheumatoid arthritis drugs called disease-modifying antirheumatic drugs (DMARDs) may play a role in that reduced…  read on >  read on >

THURSDAY, Jan. 27, 2022 (American Heart Association News) — Dr. Jeremiah Stamler, a trailblazing cardiologist who helped people understand the critical connection between healthy lifestyle and heart health – and who continued his passionate work well beyond his 100th birthday – died early Wednesday. Stamler, known as “the father of preventive cardiology,” was 102. He…  read on >  read on >

Red wine may be a guilty pleasure, but new research shows it might also be a powerful weapon against the ravages of Parkinson’s disease. Why? The antioxidants in red wine, and fruit such as berries for that matter, might slow progression of the movement disorder, a new study suggests. According to researchers, people with Parkinson’s…  read on >  read on >